Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide for paraduodenal pancreatitis
2009-016082-29Phase 2Completed
- Sponsor
- Erasmus Hospital
- Start
- Nov 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial in Groove pancreatitis (GP) and chronic pancreatitis (CP) comparing Lanreotide 90 mg with Placebo (2 arms). Started Nov 2009; status: completed.
02
Drugs
lanreotide
03
Conditions
Groove pancreatitis (GP)chronic pancreatitis (CP)
Beyond the preview
Go deeper on 2009-016082-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016082-29.